Ziad Bakri is a portfolio manager in the U.S. Equity Division of T. Rowe Price. He is president of the Investment Advisory Committee of the Health Sciences Strategy. In addition, he is a vice president and an Investment Advisory Committee member of the Blue Chip Growth, New America Growth, New Horizons, Mid-Cap Growth, and Tax-Efficient Equity Strategies. Mr. Bakri is also an Investment Advisory Committee member of the Global Growth Stock Strategy and a vice president of the Emerging Europe Strategy. Previously, he was an investment analyst in the U.S. Equity Division, covering biotechnology in the health care sector. Mr. Bakri is a vice president of T. Rowe Price Group, Inc.
University of Nottingham
Years at T. Rowe Price
Years investment experience
Tap to dismiss
Please reference the email we sent you and click the link to confirm. If you don't see an email, please check your spam folder or request another email.
We need to confirm your email.
We've been unable to send a confirmation through to the email address provided. Please kindly confirm your email address to complete your subscription and start receiving email updates.